DPIIT recognised startup Government of India
Startup India
Crozil Pharmaceuticals Private Limited - pharma in Ballabgarh, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹55,000
▼ 96% YoY
Net loss · FY 2023
₹2.7 Lakh
Net margin -491.5%
EBITDA · FY 2023
-₹40,000
EBITDA margin -72.7%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹13.87 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
1
Provident fund records
About Crozil Pharmaceuticals Private Limited
Data last updated:
Crozil Pharmaceuticals Private Limited is a private limited company based in Ballabgarh, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U93090HR2018PTC073951. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Shilpi Shiwangi and Rakesh Vasisht.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 46 Bhagat Singh Colony, Ballabgarh, Haryana, India – 121004.
As per the financials filed for FY 2023, the company reported a revenue of ₹55,000, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹2.7 Lakh (net margin -491.5%) and EBITDA of -₹40,000 (EBITDA margin -72.7%). Revenue has declined at a compounded annual rate (CAGR) of 75% over three years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹13.87 Lakh on record.
Crozil Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-20-0001599). For more details, the company can be reached via its website crozilindia.com.
Company details
CIN U93090HR2018PTC073951
Registration Number 073951
Incorporation Date 07 May 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-JH-20-0001599
Key People
Shilpi Shiwangi Director Rakesh Vasisht Director Recognitions & Rankings of Crozil Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JH-20-0001599
Contact details
Crozil Pharmaceuticals Private Limited's registered office is in Ballabgarh, Haryana. Its website is crozilindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address46 Bhagat Singh Colony, Ballabgarh, Haryana, India – 121004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Crozil Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Crozil Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Crozil Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Crozil Pharmaceuticals Private Limited, buy the company report.
Financials of Crozil Pharmaceuticals Private Limited
FY 2023 filings availableCrozil Pharmaceuticals Private Limited reported revenue of ₹55,000 (down 96% YoY) for FY 2023.
Revenue · FY 2023
₹55,000 ▼ 96%
Net loss · FY 2023
₹2.7 Lakh margin -491.5%
EBITDA · FY 2023
-₹40,000 margin -72.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 96%
3 years · compounded
▼ 75%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▼ 32%
Revenue has declined at a compounded annual rate (CAGR) of 75% over three years, including a 96% fall in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹55,000 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹40,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -72.7% | ||||
| Net Profit Margin | -491.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crozil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Crozil Pharmaceuticals Private Limited
Crozil Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpi Shiwangi | Director | 18 Jul 2019 | 7 Years 3 Months | Current |
| Rakesh Vasisht Also directs: Crozil Life Sciences (OPC) Private Limited | Director | 07 May 2018 | 8 Years 6 Months | Current |
Auditor
Crozil Pharmaceuticals Private Limited is audited by RAVI S KUMAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI S KUMAR & CO. | FY 2023 | 022334C |
Shareholding
The shareholding of Crozil Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Crozil Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.87 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Apr 2020 | 100334172 | State Bank of India | ₹13.87 Lakh | Open |
To see the full charge records of Crozil Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Crozil Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crozil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Crozil Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Dec 2021, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Employee growth
-50%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2021-22 | 1 |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Crozil Pharmaceuticals Private Limited, buy the company report.
GST
Crozil Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Crozil Pharmaceuticals Private Limited, buy the company report.
Recent activity
Crozil Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Vikas Kaushik ceased to be Director on 24 Apr 2020.
AGM
Crozil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Crozil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Charges
A charge with State Bank Of India of Rs. 13.87 Lakh registered on 22 Apr 2020 with Charge ID 100334172 was modified on 12 Aug 2021.
Ceased
Vikas Kaushik ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 13.87 Lakh with Charge ID 100334172 was registered on 22 Apr 2020.
Appointed
Shilpi Shiwangi was appointed as Director.
Appointed
Rakesh Vasisht was appointed as Director.
Incorporation
07 May 2018
Crozil Pharmaceuticals Private Limited was registered on 07 May 2018 with Roc Delhi & aged 8 years 6 months as per MCA records.
Frequently asked questions
Crozil Pharmaceuticals is an active private limited company based in Ballabgarh, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 2018 (8+ years old) and is registered under CIN U93090HR2018PTC073951.
Crozil Pharmaceuticals has 2 current directors:
- Shilpi Shiwangi - Director
- Rakesh Vasisht - Director
The latest financial statements of Crozil Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
No. Crozil Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Crozil Pharmaceuticals is U93090HR2018PTC073951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crozil Pharmaceuticals was incorporated on 07 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Vikas Kaushik ceased to be Director on 24 Apr 2020. Shilpi Shiwangi was appointed as Director on 18 Jul 2019. Rakesh Vasisht was appointed as Director on 07 May 2018.
Yes, Crozil Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Crozil Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-20-0001599).
Crozil Pharmaceuticals can be reached through the website crozilindia.com. Its registered office is in Ballabgarh, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages